[NDRA] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[NDRA] ENDRA Life Sciences Inc.
Announcement Date
07-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -92.99%
YoY- -96.43%
Quarter Report
NDRA's Result
NDRA's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 0 0 0 0 58 0 510 -
PBT -3,199 -2,894 -2,334 -1,847 -1,432 -729 -845 24.81%
Tax 1 5 0 -0 0 0 0 -
NP -3,199 -2,894 -2,334 -1,847 -1,432 -729 -845 24.81%
Tax Rate - - - - - - - -
Total Cost 3,199 2,894 2,334 1,847 1,490 729 1,355 15.37%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 -2,478.35 0.00 -165.60 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -1.54 -3.93 -6.29 -9.42 -11.75 -3.73 -27.24 -38.02%
EPS Diluted -1.54 -3.93 -6.29 -9.42 -11.75 -3.73 -26.64 -37.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.